![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » IMCLONE GOES UP AGAINST PATENT DISPUTE
IMCLONE GOES UP AGAINST PATENT DISPUTE
More bad news could be looming for ImClone Systems, the biotech maker at the heart of the Martha Stewart stock scandal. A federal judge is expected to rule, possibly within weeks, on a bitter patent dispute affecting ImClone's sole product, cancer drug Erbitux.
USA Today (http://www.usatoday.com/money/industries/health/drugs/2006-09-14-imclone-usat_x.htm?csp=N008)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct